1. VASCULAR ACCESS FOR HEMODIALYSIS
dr. Niko Azhari Hidayat, SpBTKV, MARS
Divisi Bedah Toraks Kardiovaskular
RS Universitas Airlangga
Surabaya

2. Hemodialysis access
The number of patients with end-stage renal disease (ESRD) in the United States has increased steadily.
2030: 2.24 million patients with ESRD.
The creation and maintenance of functioning vascular access, along with the associated complications, constitute the most common cause of morbidity, hospitalization, and cost in patients with end-stage renal disease.

3. Vascular System Internal Jugular Vein External Jugular Vein
Superior Vena Cava
Brachlocephalic Vein
Subclavian Vein
Cephalic Vein
Axillary Vein
Brachial Vein
Inferior Vena Cava

4. Vascular Access via Percutaneous Catheters
useful method of gaining immediate access to the circulation.
associated with higher risks.
the use-life of this type of access is shorter than that of AVFs.
Noncuffed catheters
Short term: <3 weeks

5. Vascular Access via Percutaneous Catheters: cuffed catheters
Patients who will require long-term access should have a tunneled catheter placed.
allow so-called no-needle dialysis with high flow rates
eliminate the problem of vascular steal
placed in a subcutaneous tunnel under fluoroscopic guidance

6. Vascular Access via Percutaneous Catheters: cuffed catheters
The Dacron cuff allows tissue ingrowth that helps reduce the risk of infection when compared with noncuffed catheters.

7. Hemodialysis access: complications
Complications can be divided into those that occur secondary to catheter placement and those that occur later.
The early complications of subclavian or internal jugular placement include pneumothorax, arterial injury, thoracic duct injury, air embolus, inability to pass the catheter, bleeding, nerve injury, and great vessel injury.

8. Hemodialysis access: complications
A chest radiograph must be taken after catheter placement to rule out pneumothorax and injury to the great vessels and to check for position of the catheter.
The incidence of pneumothorax is 1% to 4%,the incidence of injury to the great vessels is less than 1%.
Thrombotic complications occur in 4% to 10% of patients
Infection may occur soon after placement (3 to 5 days) or late in the life of the catheter and may be at the exit site or the cause of catheter-related sepsis.
Rate of infection between 0.5 and 3.9 episodes per 1000 catheter-days.
Catheter thrombosis increases the incidence of catheter sepsis.

9. Vascular Access via Arteriovenous Fistulas
Quality of life and overall outcome could be improved significantly for hemodialysis patients if two primary goals were achieved:
Increased placement of native AVFs: a minimum of 50% of new dialysis patients should have primary AVFs.
Detection of dysfunctional access before thrombosis of the access route occurs.
National Kidney Foundation Dialysis Outcome and Quality Initiative (NKF-DOQI)

10. Vascular Access via Arteriovenous Fistulas

11. Vascular Access via Arteriovenous Fistulas
The ideal vascular access
permits a flow rate that is adequate for the dialysis prescription (300 ml/min),
can be used for extended periods,
and has a low complication rate.
The native AVF remains the gold standard

12. KDOQI- Vascular Access
5.2 Intervention: Intervention on a fistula should be performed for the presence of:
5.2.1 Inadequate flow to support the prescribed dialysis blood flow. (B)
5.2.2 Hemodynamically significant venous stenosis. (B)
5.2.3 Aneurysm formation in a primary fistula. Postaneurysmal stenosis that drives aneurysm also should be corrected. The aneurysmal segment should not be cannulated. (B)
5.2.4 Ischemia in the access arm (B).

13. Arteriovenous fistulas
The standard by which all other fistulas are measured, is the Brescia-Cimino fistula. (2 year patency: 55% to 89%)
radial branch-cephalic direct access (snuffbox fistula),
autogenous ulnar-cephalic forearm transposition,
autogenous brachial-cephalic upper arm direct
access (antecubital vein to the brachial artery),
autogenous brachial-basilic upper arm transposition (basilic vein transposition).
These options should be exhausted before nonautogenous material is used for dialysis access.

14. Noninvasive Criteria for Selection of Upper-Extremity Arteries and Veins for Dialysis Access Procedures
Venous examination    Venous luminal diameter ³ 2.5 mm for autogenous AVFs, ³ 4.0 mm for       bridge AV grafts    Absence of segmental stenoses or occluded segments    Continuity with the deep venous system in the upper arm    Absence of ipsilateral central vein stenosis or occlusion Arterial examination    Arterial luminal diameter ³ 2.0 mm    Absence of pressure differential ³ 20 mm Hg between arms    Patent palmar arch

15. radiocephalic fistula (anatomic snuff-box)
radiocephalic fistula (Brescia-Cimino)

16. Vascular access via AVFs:
brachiocephalic fistula
brachiobasilic fistula

17. When is an AVF mature? Soft  firm and thin  thick wall
Diameter of vessel increasing (2mm  4mm)
No collaterals detracting form the main conduit
Able to visualize and feel sites appropriate for cannulation

20. Prosthetic Grafts for vascular access
Upper arm grafts have a high flow rate and a low incidence of thrombosis.
higher incidence of ischemia in the hand
higher rate of stenosis, sec to endothelial hyperplasia.

21. Femoral Vascular Access for Hemodialysis

22. Arteriovenous fistulas: Complications
Failure to mature
Stenosis at the proximal venous limb (48%).
Thrombosis (9%)
Aneurysms (7%)
Heart failure
The arterial steal syndrome and its ensuing ischemia occur in about 1.6%: pain, weakness, paresthesia, muscle atrophy, and, if left untreated, gangrene
Venous hypertension distal to the fistula : distal tissue swelling, hyperpigmentation, skin induration, and eventual skin ulceration.

23. Options for treating steal
DRIL procedure
distal revascularization-interval ligation
excision of a portion of the vein
plication w/ mattress or continuous sutures
crossed PTFE band
interposition of a 4 mm PTFE

24. Treatment of venous access complications.
Venous angioplasty
Graft thrombolysis

25. Contraindications to Thrombolytic Therapy
Absolute  
  Recent major bleeding   Recent stroke   Recent major surgery or trauma   Irreversible ischemia of end organ   Intracranial pathology   Recent ophthalmologic procedure
Relative   
History of gastrointestinal bleeding or active peptic ulcer disease   Underlying coagulation abnormalities   Uncontrolled hypertension   Pregnancy   Hemorrhagic retinopathy

26. HD Monitor Parameters Dialysis Adequacy Vascular Access Flow
Delivered Blood Flow
Recirculation
Vascular Access Flow
Cardiac Output

27. Access Flow Measurement (Blood Lines are Reversed)

28. K/DOQI Guidelines

29. K/DOQI Guidelines for Monitoring AV Grafts and Fistulas
Access flow < 600 ml/min, the patient should be referred for fistulagram.
Access flow < 1000ml/min that has decreased by > 25% over 4 months should be referred for fistulagram.

31. Message for the Surgeon - By a Surgeon Why only AV Fistulas?
You should do this because:
Patients with AVFs live longer
Patients with AVFs have 8x fewer access complications
You will like:
High patient and nephrologist satisfaction
Simple, safe outpatient procedures
Avoid or markedly decrease hospital admissions and emergency operations for infection, bleeding, steal syndrome, and thrombosis.
William Jennings, MD, Tulsa Vascular Access Surgeon

32. Reference:
1.Quinton WE, Dillard D, Scribner BH: Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif intern Organs 6:104, 1960
2. NKF-K/DOQI Clinical Practice Guidelines For Vascular Access: Guideline 29: goals of access placement – maximizing primary AV fistulae. Am J Kidney Dis 37 (Suppl 1): S169, 2001
3. Churchill DN, Taylor DW, Cook RI, Laplante P. Barre P. Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie 1K, Muirhead N, Parfrey PS, Posen GA: Canadian hemodialysis morbidity study. Am I Kidney Dis 19: , 1992
4. Mehta S: Statistical summary of clinical results of vascular access procedures for haemodialysis, in Summer BG, Henry ML (eds): Vascular Access for Hemodialysis— II. W.L. Gore & Associates, 1991, pp
5. NKF-K/DOQI Clinical Practice Guidelines For Vascular Access: Guideline 3: selection of permanent vascular access and order of preference for placement of AV fistulae. Am J Kidney Dis 37 (Suppl 1): S
6. Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int 60: , 2001
7. Ascher E, Hingorani AP, Yorkovich WR: Techniques and outcome after brachiocephalic and brachiobasilic arteriovenous fistula creation, in A Multidisciplinary Approach for Hemodialysis Access, edited by Gray R and Sands J, New York New York, Lippincott Williams & Wilkins, 2002, pp 84-92
8. NKF-K/DOQI Clinical Practice Guidelines For Vascular Access: Guideline 9: access maturation. Am J Kidney Dis 37 (Suppl 1): S , 2001
9. Pisoni RL, Young EW, Mapes DL, Keen ML, Port FK. Vascular access use and outcomes in the U.S., Europe, and Japan: results from the Dialysis Outcomes and Practice Patterns Study. Nephrol News Issues. 17:38-43, 2003

33. Cont’
10. Beathard, GA: Complications of vascular access. In: Complications of Dialysis – Recognition and Management. Edited by Lameire, N and Mehta, R. Marcel Dekker, Inc, New York. 2000, pp 1-27
11. Tordoir JH, Rooyens P, Dammers R, Van Der Sande FM, De Haan M, Yo TI: Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant18:378-83, 2003
12. NKF-K/DOQI Clinical Practice Guidelines For Vascular Access: Guideline 8: timing of access placement. Am J Kidney Dis 37 (Suppl 1): S , 2001
13. NKF-K/DOQI Clinical Practice Guidelines For Vascular Access: Guideline 1: Patient history and physicial examination prior to permanent access selections. Am J Kidney Dis 37 (Suppl 1): S141, 2001
14. Silva MB Jr, Hobson RW 2nd, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, Gwertzman G, Padberg FT Jr: A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 27: , 1998
15. Robbin ML, Gallichio MH, Deierhoi MH, Young CJ, Weber TM, Allon M. US vascular mapping before hemodialysis access placement. Radiology. 217:83-88, 2000
16. Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, Deierhoi MH, Robbin ML. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 60: , 2001
17. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 63: , 2003
18. Kamienski RW, Barnes RW: Critique of the Allen test for continuity of the palmar arch assessed by Doppler ultrasound. Surg Gynecol Obstet 142: , 1976

34. THANK YOU